Business GrowthOwens & Minor's acquisition of Rotech strengthens the Patient Direct segment while also bolstering current margins and cash flow generation profile.
Financial PerformanceAdjusted EBITDA expanded 12.4%, reflecting improved operational efficiency.
Strategic ExpansionRotech allows Owens & Minor to further penetrate respiratory, sleep apnea, diabetes, and wound care markets as well as bring a higher EBITDA margin business into the portfolio.